Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Cuthbertson

Showing results (111-120 of 241) with videos related to

Pageof 25
Sort By:
Endocrine Journal|May 24, 2008
Lymphocytic hypophysitis occurring simultaneously with a functioning pituitary adenomaDaniel J Cuthbertson, Dave Ritchie, Daniel Crooks, et al.
European Journal of Endocrinology|August 6, 2010
Pituitary adenomas in childhood, adolescence and young adulthood: presentation, management, endocrine and metabolic outcomesCaroline A Steele, Ian A MacFarlane, Joanne Blair, et al.
Contemporary Clinical Trials|December 17, 2016
EffectS of non-nutritive sWeetened beverages on appetITe during aCtive weigHt loss (SWITCH): Protocol for a randomized, controlled trial assessing the effects of non-nutritive sweetened beverages compared to water during a 12-week weight loss period and a follow up weight maintenance periodU Masic, J A Harrold, P Christiansen, et al.
BMC Veterinary Research|August 30, 2012
Obesity-related metabolic dysfunction in dogs: a comparison with human metabolic syndromeAsta Tvarijonaviciute, Jose J Ceron, Shelley L Holden, et al.
European Journal of Endocrinology|December 22, 2012
Low prevalence of hypopituitarism after subarachnoid haemorrhage using confirmatory testing and with BMI-specific GH cut-off levelsChris J Gardner, Mohsen Javadpour, Catherine Stoneley, et al.
Diabetes, Obesity & Metabolism|March 5, 2013
Effects of 6 months glucagon-like peptide-1 receptor agonist treatment on endothelial function in type 2 diabetes mellitus patientsN D Hopkins, D J Cuthbertson, G J Kemp, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|July 4, 2020
Mechanisms, screening modalities and treatment options for individuals with non-alcoholic fatty liver disease and type 2 diabetesT J Hydes, N Summers, E Brown, et al.
Diabetes Research and Clinical Practice|February 23, 2026
Long-term adverse multi-system health outcomes of gestational diabetes mellitus: an analysis of real-world cohort dataMegan O Heague, Alex E Henney, David R Riley, et al.
Clinical Therapeutics|May 1, 2018
Diabetic Peripheral Neuropathy: Epidemiology, Diagnosis, and PharmacotherapyZohaib Iqbal, Shazli Azmi, Rahul Yadav, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2013
Treatment of orbital metastases from a primary midgut neuroendocrine tumor with peptide-receptor radiolabeled therapy using 177 lutetium-DOTATATERebecca Dobson, Sobhan Vinjamuri, James Hsuan, et al.
Pageof 25

Showing results (111-120 of 241) with videos related to

Sort By:
Pageof 25
Endocrine Journal|May 24, 2008
Lymphocytic hypophysitis occurring simultaneously with a functioning pituitary adenomaDaniel J Cuthbertson, Dave Ritchie, Daniel Crooks, et al.
European Journal of Endocrinology|August 6, 2010
Pituitary adenomas in childhood, adolescence and young adulthood: presentation, management, endocrine and metabolic outcomesCaroline A Steele, Ian A MacFarlane, Joanne Blair, et al.
Contemporary Clinical Trials|December 17, 2016
EffectS of non-nutritive sWeetened beverages on appetITe during aCtive weigHt loss (SWITCH): Protocol for a randomized, controlled trial assessing the effects of non-nutritive sweetened beverages compared to water during a 12-week weight loss period and a follow up weight maintenance periodU Masic, J A Harrold, P Christiansen, et al.
BMC Veterinary Research|August 30, 2012
Obesity-related metabolic dysfunction in dogs: a comparison with human metabolic syndromeAsta Tvarijonaviciute, Jose J Ceron, Shelley L Holden, et al.
European Journal of Endocrinology|December 22, 2012
Low prevalence of hypopituitarism after subarachnoid haemorrhage using confirmatory testing and with BMI-specific GH cut-off levelsChris J Gardner, Mohsen Javadpour, Catherine Stoneley, et al.
Diabetes, Obesity & Metabolism|March 5, 2013
Effects of 6 months glucagon-like peptide-1 receptor agonist treatment on endothelial function in type 2 diabetes mellitus patientsN D Hopkins, D J Cuthbertson, G J Kemp, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|July 4, 2020
Mechanisms, screening modalities and treatment options for individuals with non-alcoholic fatty liver disease and type 2 diabetesT J Hydes, N Summers, E Brown, et al.
Diabetes Research and Clinical Practice|February 23, 2026
Long-term adverse multi-system health outcomes of gestational diabetes mellitus: an analysis of real-world cohort dataMegan O Heague, Alex E Henney, David R Riley, et al.
Clinical Therapeutics|May 1, 2018
Diabetic Peripheral Neuropathy: Epidemiology, Diagnosis, and PharmacotherapyZohaib Iqbal, Shazli Azmi, Rahul Yadav, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2013
Treatment of orbital metastases from a primary midgut neuroendocrine tumor with peptide-receptor radiolabeled therapy using 177 lutetium-DOTATATERebecca Dobson, Sobhan Vinjamuri, James Hsuan, et al.
Pageof 25